Renal Cancer - Results from #1420

An oncogenic JMJD6-DGAT1 axis tunes the epigenetic regulation of lipid droplet formation in clear cell renal cell carcinoma. July 1, 2022

A clinical investigation of recurrence and lost follow-up after renal cell carcinoma surgery: a single-center, long-term, large cohort, retrospective study. July 1, 2022

Real World Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Only Available Sunitinib and Pazopanib in First-Line Setting. June 30, 2022

Systemic Immunological Determinants of Oncological Outcomes After Surgery for Localized Renal Cell Carcinoma. June 30, 2022

Therapeutic sequencing in the era of first-line immune checkpoint inhibitor combinations, a novel challenge in patients with metastatic clear-cell renal cell carcinoma. June 29, 2022

A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear Cell Renal Cell Carcinoma. June 29, 2022

Unplanned Conversion from Partial to Radical Nephrectomy - An Analysis of Incidence, Etiology, and Risk Factors. June 28, 2022

Impact of dedicated renal enhanced recovery after surgery (RERAS) program on postoperative opioid consumption and evaluation of surgeon-specific compliance to the program. June 28, 2022

Construction and validation of a novel prognostic nomogram for patients with metastatic renal cell carcinoma: a SEER-based study. June 27, 2022

Noncoding-RNA mediated high expression of zinc finger protein 268 suppresses clear cell renal cell carcinoma progression by promoting apoptosis and regulating immune cell infiltration. June 27, 2022

Redo Robotic Partial Nephrectomy for Recurrent Renal Tumors: A Multi-Institutional Analysis. June 24, 2022

Heterogeneity of Platelet Derived Growth Factor Pathway Gene Expression Profile Defines Three Distinct Subgroups of Renal Cell Carcinomas. June 24, 2022

Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline. June 23, 2022

Percutaneous cryoablation for clinical T3a renal cell carcinoma (< 7 cm) with segmental vein involvement or perinephric fat invasion based on preoperative evaluation of high-resolution multidetector computed tomography scan. June 23, 2022

Aberrant MEK5 signalling promotes clear cell renal cell carcinoma development via mTOR activation. June 22, 2022

Special issue "The advance of solid tumor research in China": Presurgical therapy in the management of local retroperitoneal recurrence of renal cell carcinoma after radical nephrectomy. June 22, 2022

Immune-Associated Gene Signatures Serve as a Promising Biomarker of Immunotherapeutic Prognosis for Renal Clear Cell Carcinoma. June 21, 2022

KCNN4 may weaken anti-tumor immune response via raising Tregs and diminishing resting mast cells in clear cell renal cell carcinoma. June 21, 2022

Young age is associated with decreased recurrence for renal cell carcinoma. June 20, 2022

Bioinformatic Analysis Identifying PSMB 1/2/3/4/6/8/9/10 as Prognostic Indicators in Clear Cell Renal Cell Carcinoma. June 20, 2022

Page 72 of 456